0001225208-22-002932.txt : 20220222
0001225208-22-002932.hdr.sgml : 20220222
20220222164651
ACCESSION NUMBER: 0001225208-22-002932
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220217
FILED AS OF DATE: 20220222
DATE AS OF CHANGE: 20220222
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Pierce David A
CENTRAL INDEX KEY: 0001529751
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-11083
FILM NUMBER: 22658931
MAIL ADDRESS:
STREET 1: BOSTON SCIENTIFIC CORPORATION
STREET 2: 300 BOSTON SCIENTIFIC WAY
CITY: MARLBOROUGH
STATE: MA
ZIP: 01752-1234
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BOSTON SCIENTIFIC CORP
CENTRAL INDEX KEY: 0000885725
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 042695240
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 300 BOSTON SCIENTIFIC WAY
CITY: MARLBOROUGH
STATE: MA
ZIP: 01752-1234
BUSINESS PHONE: 508-683-4000
MAIL ADDRESS:
STREET 1: 300 BOSTON SCIENTIFIC WAY
CITY: MARLBOROUGH
STATE: MA
ZIP: 01752-1234
4
1
doc4.xml
X0306
4
2022-02-17
0000885725
BOSTON SCIENTIFIC CORP
BSX
0001529751
Pierce David A
300 BOSTON SCIENTIFIC WAY
MARLBOROUGH
MA
01752-1234
1
EVP Pres MedSurg
Common Stock
2022-02-17
4
M
0
3333.0000
0.0000
A
3333.0000
D
Common Stock
2022-02-17
4
F
0
979.0000
42.8300
D
2354.0000
D
Common Stock
2022-02-18
4
M
0
2668.0000
0.0000
A
5022.0000
D
Common Stock
2022-02-18
4
F
0
784.0000
42.5500
D
4238.0000
D
Common Stock
2022-02-18
4
S
0
2354.0000
42.8800
D
1884.0000
D
Restricted Stock Units
2022-02-17
4
M
0
3333.0000
0.0000
D
2025-02-17
Common Stock
3333.0000
10000.0000
D
Deferred Stock Units
2022-02-18
4
M
0
2668.0000
0.0000
D
2024-02-18
Common Stock
2668.0000
5337.0000
D
Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-l trading plan.
Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 17, 2022, the first anniversary of the date of grant.
Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 18, 2021, the first anniversary of the date of grant.
/s/ Susan Thompson, Attorney-in-Fact
2022-02-19